DIA 2013 49th Annual Meeting
Click here to go to the previous page
Pharma, Academia and CRO Preferred Partnerships: Why Collaboration Makes a Better Global Trial
Track
:
Track 03: Innovative Partnering Models and Outsourcing Strategies
Program Code:
245
Date:
Tuesday, June 25, 2013
Time:
1:45 PM to 3:15 PM
EST
Location:
104AB
CHAIR
:
Mary Ann Sellers, MSN (SCHNON), Senior Project Leader, Duke Clinical Research Institute, United States
SPEAKER
(S):
Joe Zimmerman, (SPKNON), Senior Director, R&D Business Operations, Amylin Pharmaceuticals, Inc., United States Michelle Masterson, (SPKNON), Project Manager, Diabetes Trials Unit, Oxford University, United Kingdom
Sara Tullberg, PhD (SPKNON), Senior Project Leader, PAREXEL International, United Kingdom
Description
This session will describe successful strategies used by a multi-partner collaboration to manage challenges encountered in an ongoing "megatrial." The team will share structural and operational models that have been used to drive novel solutions.
This session is a part of:
This session is a part of: